131 related articles for article (PubMed ID: 15063914)
1. Training rural practitioners to use buprenorphine; using The Change Book to facilitate technology transfer.
McCarty D; Rieckmann T; Green C; Gallon S; Knudsen J
J Subst Abuse Treat; 2004 Apr; 26(3):203-8. PubMed ID: 15063914
[TBL] [Abstract][Full Text] [Related]
2. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
Cunningham CO; Sohler NL; McCoy K; Kunins HV
Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
4. Opiate dependence treatment with buprenorphine: one year's experience in a family practice residency setting.
Colameco S; Armando J; Trotz C
J Addict Dis; 2005; 24(2):25-32. PubMed ID: 15784521
[TBL] [Abstract][Full Text] [Related]
5. Managing opioid addiction with buprenorphine.
Donaher PA; Welsh C
Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
[TBL] [Abstract][Full Text] [Related]
6. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine diffusion: the attitudes of substance abuse treatment counselors.
Knudsen HK; Ducharme LJ; Roman PM; Link T
J Subst Abuse Treat; 2005 Sep; 29(2):95-106. PubMed ID: 16135338
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine for office-based treatment of patients with opioid addiction.
Manlandro JJ
J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
[TBL] [Abstract][Full Text] [Related]
9. In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants.
Barnett ML; Lee D; Frank RG
Health Aff (Millwood); 2019 Dec; 38(12):2048-2056. PubMed ID: 31794302
[TBL] [Abstract][Full Text] [Related]
10. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
Costa E Silva JA
Hum Psychopharmacol; 2004 Jun; 19(4):215-24. PubMed ID: 15181649
[TBL] [Abstract][Full Text] [Related]
11. Determinants of buprenorphine treatment for opioid dependence.
Murphy SM; Fishman PA; McPherson S; Dyck DG; Roll JR
J Subst Abuse Treat; 2014 Mar; 46(3):315-9. PubMed ID: 24209382
[TBL] [Abstract][Full Text] [Related]
12. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
Stock C; Shum JH
J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
[TBL] [Abstract][Full Text] [Related]
13. Helping 'them': our role in recovery from opioid dependence.
Loxterkamp D
Ann Fam Med; 2006; 4(2):168-71. PubMed ID: 16569721
[TBL] [Abstract][Full Text] [Related]
14. Using buprenorphine for outpatient opioid detoxification.
Manlandro JJ
J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
Turner BJ; Laine C; Lin YT; Lynch K
Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
[TBL] [Abstract][Full Text] [Related]
16. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
[TBL] [Abstract][Full Text] [Related]
17. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
[TBL] [Abstract][Full Text] [Related]
18. Methadone medical maintenance in primary care. An implementation evaluation.
Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
[TBL] [Abstract][Full Text] [Related]
19. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
[TBL] [Abstract][Full Text] [Related]
20. A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.
Rieckmann TR; Kovas AE; McFarland BH; Abraham AJ
J Subst Abuse Treat; 2011 Dec; 41(4):374-85. PubMed ID: 21821379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
